Please complete the CAPTCHA to continue
@sparktx.com
✓
2 phones found area 214
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Irene Rombel is listed as CEO and Co-founder, BioCurie | Harnessing AI to Transform Cell and Gene Therapy Manufacturing at BioCurie, based in Greater Philadelphia, United States. AeroLeads shows a work email signal at sparktx.com, phone signal with area code 214, and a matched LinkedIn profile for Irene Rombel.
Irene Rombel previously worked as CEO and Co-Founder at Biocurie and Advisory Board Member at Columbia University Irving Medical Center. Irene Rombel holds Ph.D., Biochemistry (Thesis Title: Pyoverdine Genes Of Pseudomonas Aeruginosa) from University Of Otago.
This section adds company-level context without repeating Irene Rombel's masked contact details.
AeroLeads found 1 current-domain work email signal for Irene Rombel. Compare company email patterns before reaching out.
My passion is to be at the convergence of innovative technologies spanning life science, Big Data and beyond. I am committed to transforming great science into differentiated products that will help society, while creating shareholder value. With a career that spans academia, biopharma, the investment industry, and founding my own consulting business, I have a proven track record in creating value by leveraging my skills in science, technology and business. I thrive on leading, organizing and collaborating with internal and external stakeholders, and helping organizations leverage new opportunities emerging from a rapidly evolving global ecosystem. Highlights of Expertise:• Strategy & Corporate Development •External Innovation • Science & Technology • Gene Therapy • Cell Therapy • Non-viral Delivery • Nucleic Acid Therapy & Vaccines • mRNA • Antibodies• Big Data • Artificial Intelligence & Machine Learning • Bioinformatics • Knowledge Management• Drug Discovery & Development • Life Science Tools and Diagnostics • Medical Devices• Business Development • Investment Analysis • Competitive & Market Analysis • IP Strategy• Operations • Communications • Investor Relations
Listed skills include Biotechnology, Lifesciences, Genomics, Strategic Planning, and 24 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
I co-founded BioCurie with the vision of revolutionizing cell and gene therapy production to bring these therapies from niche into mainstream medicine. Our goal is to harness AI to transform cell and gene therapy manufacturing.
New York, New York, Us
The Irving Cancer Drug Discovery Program is an exciting, new initiative launched in 2023. is to build the critical infrastructure and support needed to accelerate the development of scientific discoveries into new therapies spanning a broad range of modalities, including small molecules, antibodies & ADCs, and cell therapies. The program also supports innovative technologies to enable diagnosis and early detection.
Raritan, New Jersey, Us
Raritan, New Jersey, Us
Raritan, New Jersey, Us
As an Advisor to ORIG3N, an adult induced pluripotent stem cells (iPSC) start up company, I provide strategic advice on intellectual property, commercial opportunities, competitive landscape, and scientific & clinical progress in this rapidly growing field.
As an Advisor to GenPro, an epigenetic machine learning company, I provide advice on developing strategies for proof of concept studies, intellectual property, and commercialization in this increasingly important area of genomics.
I founded Biomedical Intelligence in 2008 in order to provide consulting services focused on the life sciences, drawing upon my expertise in science, intellectual property, and business development. I work with life science & healthcare companies, universities & academic hospitals, and investors to provide proprietary research and advice. My services include technology evaluation, diligence for M&A and licensing, strategic planning, business development, and market analysis. In addition, I am a US Registered Patent Agent, which enables me to assess intellectual property in terms of strength, value and commercial potential.My areas of focus include biotechnology, pharmaceuticals, life science tools and diagnostics.
As part of a multisector investment team focused on microcap stocks, I executed proprietary research on publicly traded companies in the life science and healthcare sectors. The companies in my universe spanned biotechnology, pharmaceuticals, specialty pharma, medical devices, research tools/reagents, and diagnostic tests and services.
As part of a multi-sector investment group, I conducted proprietary research and diligence on publicly traded companies in the life science and healthcare sectors.
As part of a small team focused exclusively on investing in the biomedical sector, executed proprietary research and diligence on public and private companies.
Dallas, Texas, Us
While starting out as a Research Assistant Professor at the Center for Biomedical Inventions, conducting reseach on vaccines and cell-specific targeting, I transitioned to leading business developement and intellectual property efforts for the group.
Quick answers generated from the profile data available on this page.
Irene Rombel works for BioCurie.
Irene Rombel is listed as CEO and Co-founder, BioCurie | Harnessing AI to Transform Cell and Gene Therapy Manufacturing at BioCurie.
AeroLeads has found 1 work email signal at @sparktx.com for Irene Rombel at BioCurie.
AeroLeads has found 2 phone signal(s) with area code 214 for Irene Rombel at BioCurie.
Irene Rombel is based in Greater Philadelphia, United States while working with BioCurie.
Irene Rombel has worked for Biocurie, Columbia University Irving Medical Center, Spark Therapeutics, Inc., The Janssen Pharmaceutical Companies Of Johnson & Johnson, and Orig3N.
You can use AeroLeads to view verified contact signals for Irene Rombel at BioCurie, including work email, phone, and LinkedIn data when available.
Irene Rombel holds Ph.D., Biochemistry (Thesis Title: Pyoverdine Genes Of Pseudomonas Aeruginosa) from University Of Otago.
Irene Rombel is listed with skills including Biotechnology, Lifesciences, Genomics, Strategic Planning, Competitive Analysis, Biochemistry, Molecular Biology, and Pharmaceutical Industry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts